These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 949221

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Response and survival of patients with metastatic neuroblastoma after combination chemotherapy with adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and vincristine (NSC-67574).
    Gasparini M, Bellani FF, Musumeci R, Bonadonna G.
    Cancer Chemother Rep; 1974; 58(3):365-70. PubMed ID: 4601666
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
    Sun XF, Liu DG, Su YS, Lin TY, Chen XQ, He YJ.
    Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
    [Abstract] [Full Text] [Related]

  • 5. [Myeloablative chemo- and radiotherapy with autologous and allogenic bone marrow reconstitution in children with metastatic neuroblastoma].
    Berthold F, Bender-Götze C, Dopfer R, Erttmann R, Haas RJ, Henze G, Körbling M, Riehm H, Rister M, Stollmann B.
    Klin Padiatr; 1988 Dec; 200(3):221-5. PubMed ID: 3062259
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. ["Cellular synchronization" method in treatment of infantile tumors].
    Hurtado T, Fernández P, Muñoz Villa A, González MC, García Miguel P.
    An Esp Pediatr; 1976 Dec; 9(9):42-8. PubMed ID: 797280
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of vincristine sulfate and cyclophosphamide chemotherapy for metastatic neuroblastoma.
    Sullivan MP, Nora AH, Kulapongs P, Lane DM, Windmiller J, Thurman WG.
    Pediatrics; 1969 Nov; 44(5):685-94. PubMed ID: 5374979
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
    Horibe K, Fukuda M, Miyajima Y, Matsumoto K, Kondo M, Inaba J, Miyashita Y.
    Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical aspects and radiotherapy of stage III and IV neuroblastomas].
    Müller RP, Schmidt H, Schnepper E, Fischedick AR.
    Strahlentherapie; 1983 Nov; 159(11):661-8. PubMed ID: 6658853
    [Abstract] [Full Text] [Related]

  • 14. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy.
    Mastrangelo S, Tornesello A, Diociaiuti L, Pession A, Prete A, Rufini V, Troncone L, Mastrangelo R.
    Br J Cancer; 2001 Feb; 84(4):460-4. PubMed ID: 11207038
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. First, second and third line chemotherapy programs in metastatic breast carcinoma.
    Rizel S, Sulkes A, Gez E, Brufman G, Biran S.
    Isr J Med Sci; 1981 Feb; 17(9-10):946-53. PubMed ID: 6171542
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.